Morgan Stanley Updates Estimates On Endo Health Solutions

In a report published Monday, Morgan Stanley analyst Christopher Caponetti reiterated an Equal-Weight rating on Endo Health Solutions (NASDAQ: ENDP ). In the report, Morgan Stanley noted, “Endo's 1.75% convertible notes (due March 2015) and warrants are in-the-money and add roughly 13-15M to Endo's fully-diluted share count. Our new 2014E